Plaque reduction-based Antibody Assay Services.
The Viral Bioassay facility (VBaf) offers antibody screening assay services to validate the virus inhibition potential of your antibodies/antiviral compounds. The assay is based on the Plaque Reduction Neutralization Test (PRNT) which measures the ability of the antibodies/antiviral compounds to neutralize a virus. The antibodies already validated to show antiviral activity against the virus of interest will be used as an internal control.